Company profilePharmaceutical#629 of 1,318 in Pakistan✓ No DRAP alerts

BIOGENICS PAKISTAN (PVT) LTD.

Pharmaceutical company · 17 brands · 22 molecules

Ranked #153 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

17 registered products 16 pharmaceutical brands 22 distinct molecules 0 DRAP alerts

Company overview

17
registered products
16
pharmaceutical brands
22
distinct molecules
4
therapeutic classes
0
DRAP alerts

BIOGENICS PAKISTAN (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 17 product registrations across 22 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Calcium Channel Blockers. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BIOGENICS

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252

Top molecules by brand count

Omeprazole2 brands
Doxycycline2 brands
Naproxen1 brand
Omeprazole.........................20Mg1 brand
Omeprazole ...... 40 Mg1 brand
Calcium1 brand

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Calcium Channel Blockers · 1Antiinflammatory And Antirheumatic Products · 1Cardiac Therapy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official4 products · Rs 112.95 – Rs 455.48
DVAGO4 products · Rs 52.3 – Rs 455.48
Median across source: Rs 237.44

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Genix Pharma Private Limited15 shared molecules
SEARLE PAKISTAN (PVT.) LTD.12 shared molecules
VALOR PHARMACEUTICALS12 shared molecules
BIO LABS (PVT) LTD.11 shared molecules
PharmEvo Private Limited11 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Genix Pharma Private Limited holds 156 molecules not in this portfolio
000 I.UAceclofenacAcyclovirAlbendazoleAlfacalcidolAmikacin
GETZ PHARMA PAKISTAN (PVT) LTD. holds 273 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
Wilshire Laboratories (Private) Limited holds 133 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin

Get the full profile for BIOGENICS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.